成年期肥厚型心肌病与当代管理策略相关的低心血管死亡率

Maron等人（周五）在肥厚型心肌病队列（n=1000）中进行了研究。评估了成人肥厚型心肌病中当代管理策略对HCM相关死亡的影响。结果显示，当代管理策略使成人肥厚型心肌病的疾病相关死亡率降低至0.53%/年，5年及10年生存率分别为98%和94%。

www.synapsesocial.com/papers/69efd2c3b8a53e2a171bc996 — DOI: https://doi.org/10.1016/j.jacc.2015.02.061

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Hypertrophic Cardiomyopathy· 2014 · 640 citations
2. Risk Stratification and Outcome of Patients With Hypertrophic Cardiomyopathy ≥60 Years of Age· 2012 · 249 citations
3. Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia· 1996 · 4,159 citations
4. Evolution of Hypertrophic Cardiomyopathy to a Contemporary Treatable Disease· 2012 · 49 citations
5. Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy